S. Ahyai

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
S A Ahyai, Sascha Ahyai, S Ahyai, Sascha A Ahyai, Sascha A. Ahyai, S. Ahyai
Publication record
290 papers · 6,124 citations · H-index 35

PAPERS

Temporal Trends and Differences in Inpatient Palliative Care Use in Metastatic Penile Cancer Patients
20250 citationsauthor #12
Impact of ISUP grade group on cancer-specific mortality in radical prostatectomy-treated prostate cancer patients with organ-confined disease.
20250 citationsauthor #17
Toward Standardized Outcome Reporting in Urethral Reconstruction: Development of the “Stricture-fecta” Through an International Modified Delphi Consensus
20251 citationsauthor #18
Cancer-specific mortality after radical prostatectomy versus radiotherapy in incidental prostate cancer.
202511 citationsauthor #19
Arterial thromboembolic events in testicular cancer patients: Short- and long-term incidence, risk factors and impact on mortality.
20252 citationsauthor #11
Use of inpatient palliative care in metastatic testicular cancer patients undergoing critical care therapy: insights from the national inpatient sample
20251 citationsauthor #15
Sarcomatoid dedifferentiation as a predictor of overall mortality in surgically treated metastatic renal cell carcinoma.
20250 citationsauthor #17
Survival of stage III non‐seminoma testis cancer patients versus simulated controls, according to race/ethnicity
20242 citationsauthor #22
Differences in other-cause mortality in metastatic renal cell carcinoma according to partial vs. radical nephrectomy and age: A propensity score matched study.
20242 citationsauthor #16
Prognostic significance of lymph node count in surgically treated patients with T2-4 stage nonmetastatic adrenocortical carcinoma.
20243 citationsauthor #9
Multivariable model versus AJCC staging system: cancer-specific survival predictions in adrenocortical carcinoma.
20242 citationsauthor #16
FT-IR Spectroscopy Analysis of Kidney Stone Variability in Styria
20243 citationsauthor #6
Trends and Disparities in Inpatient Palliative Care Use in Metastatic Renal Cell Carcinoma Patients Receiving Critical Care Therapy.
20242 citationsauthor #15
Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma
20244 citationsauthor #14
Primary tumor ablation in metastatic renal cell carcinoma.
20241 citationsauthor #19
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
20246 citationsauthor #19
MP22-07 CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMA
20240 citationsauthor #16
Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer
20244 citationsauthor #14
A population-based validation of the IGCCCG Update Consortium for survival in metastatic non-seminoma testis cancer.
20244 citationsauthor #17
Regional Differences in Stage III Nonseminoma Germ Cell Tumor Patients Across SEER Registries.
20242 citationsauthor #11
Identifying low cancer‐specific mortality risk lymph node‐positive radical prostatectomy patients
20241 citationsauthor #17
The effect of adrenalectomy on overall survival in metastatic adrenocortical carcinoma.
20242 citationsauthor #9
FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies
202419 citationsauthor #7
Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment.
20243 citationsauthor #16
MP38-16 SURVIVAL BENEFIT OF NEPHROURETERECTOMY IN SYSTEMIC THERAPY EXPOSED METASTATIC UPPER TRACT URINARY UROTHELIAL CARCINOMA PATIENTS
20240 citationsauthor #19
MP01-02 PROPENSITY-MATCHED ANALYSIS OF OPEN VERSUS ROBOTIC PRIMARY RETROPERITONEAL LYMPH NODE DISSECTION FOR CS II TESTICULAR CANCER
20240 citationsauthor #14
Married Status Affects Rates of Treatment and Mortality in Male and Female Renal Cell Carcinoma Patients Across all Stages.
20243 citationsauthor #14
Unmarried Status Effect on Stage at Presentation and Treatment Patterns in Non-Metastatic Upper Tract Urothelial Carcinoma Patients.
20249 citationsauthor #17
MP10-08 SARCOMATOID DEDIFFERENTIATION AS A PREDICTOR OF OVERALL MORTALITY IN SURGICALLY TREATED METASTATIC RENAL CELL CARCINOMA
20240 citationsauthor #17
Regional differences in upper tract urothelial carcinoma patients across the United States.
202410 citationsauthor #15
Survival differences in non-seminoma testis cancer patients according to race/ethnicity.
20242 citationsauthor #11
Surgically treated pelvic liposarcoma and leiomyosarcoma: The effect of tumor size on cancer-specific survival.
20247 citationsauthor #18
Unmarried status effect on stage at presentation and treatment patterns in primary urethral carcinoma patients.
20245 citationsauthor #16
The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients
20245 citationsauthor #15
Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy
20244 citationsauthor #10
The European Network for the Study of Adrenal Tumors staging system (2015): a United States validation.
20242 citationsauthor #18
Temporal Trends and Cancer-Specific Mortality in Nonmetastatic Muscle-Invasive Urothelial Carcinoma of the Urinary Bladder Treated With Trimodal Therapy.
20242 citationsauthor #11
MP01-01 INCREMENTAL DOSE-RESPONSE EFFECT OF AGE ON MORTALITY IN NON-SEMINOMA TESTIS CANCER PATIENTS
20240 citationsauthor #14
The Effect of Surgical Resection on Cancer-Specific Mortality in Pelvic Soft Tissue Sarcoma According to Histologic Subtype and Stage
20243 citationsauthor #15
PD23-06 SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS
20240 citationsauthor #15
Intermediate- and long-term results after ATOMS (Adjustable Transobturator Male System®) implantation.
20241 citationsauthor #10
Contemporary conditional cancer‐specific survival rates in surgically treated nonmetastatic primary urethral carcinoma
20244 citationsauthor #16
Elective Urological Procedures in Times of Reduced Operating Room Capacity.
20241 citationsauthor #9
Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma
20236 citationsauthor #16
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sites.
20234 citationsauthor #17
Prostate tumor volume is a significant predictor to identify patients with no need for concomitant systematic biopsy in men undergoing transrectal ultrasound- MRI fusion guided biopsy of the prostate
20230 citationsauthor #15
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites.
202315 citationsauthor #17
Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis
20231 citationsauthor #15
Characteristics of incidental prostate cancer in the United States
202311 citationsauthor #19
Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.
20232 citationsauthor #16
Prospective evaluation of an intraoperative urodynamic stress test predicting urinary incontinence after robot-assisted laparoscopic radical prostatectomy
20234 citationsauthor #5
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery
20234 citationsauthor #11
Prognostic Significance of Radiographic Lymph Node Invasion in Contemporary Metastatic Renal Cell Carcinoma Patients.
20232 citationsauthor #19
Regional differences in penile cancer patient characteristics and treatment rates across the United States.
20235 citationsauthor #17
Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
20233 citationsauthor #17
Charlson–Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder Cancer
20234 citationsauthor #17
The Association Between Cytoreductive Nephrectomy and Overall Survival in Metastatic Renal Cell Carcinoma with Primary Tumor Size ≤4 cm.
20238 citationsauthor #17
Regional differences in metastatic urothelial carcinoma of the urinary bladder patients across the United States SEER registries.
20235 citationsauthor #13
Contemporary sex-specific analysis of the association of marital status with cancer-specific mortality in primary urethral carcinoma patients.
20237 citationsauthor #15
Conditional survival of stage III non-seminoma testis cancer patients.
20236 citationsauthor #12
The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients.
20232 citationsauthor #13
Other-Cause Mortality, According to Partial vs. Radical Nephrectomy: Age and Stage Analyses.
20234 citationsauthor #12
In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
20239 citationsauthor #16
Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls
20233 citationsauthor #21
Development and External Validation of a Novel Nomogram Predicting Cancer-specific Mortality-free Survival in Surgically Treated Papillary Renal Cell Carcinoma Patients.
20236 citationsauthor #14
The effect of married status on cancer-specific mortality in nonmetastatic pelvic liposarcoma patients according to sex.
20236 citationsauthor #12
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
20236 citationsauthor #14
Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
20231 citationsauthor #21
Differences in overall survival of penile cancer patients versus population‐based controls
20238 citationsauthor #18
Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria
20234 citationsauthor #6
Cancer-Specific Mortality Differences in Specimen-Confined Radical Prostatectomy Patients According to Lymph Node Invasion.
20232 citationsauthor #18
Which Men Do or Do Not Achieve Long-Term Symptom Relief After Holmium Laser Enucleation of the Prostate (HoLEP): 11 Years of HoLEP Experience
20223 citationsauthor #8
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer Study
202228 citationsauthor #10
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
20225 citationsauthor #27
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up
20222 citationsauthor #13
Multiparametric MRI may Help to Identify Patients With Prostate Cancer in a Contemporary Cohort of Patients With Clinical Bladder Outlet Obstruction Scheduled for Holmium Laser Enucleation of the Prostate (HoLEP)
202113 citationsauthor #10
Determination of Face and Content Validity of Cadaveric Model for Holmium Anatomic Endoscopic Enucleation of the Prostate Training: An ESUT AEEP Group Study
20219 citationsauthor #8
A call for HoLEP: en-bloc vs. two-lobe vs. three-lobe
202146 citationsauthor #5
Impact of mpMRI targeted biopsy on intraoperative nerve‐sparing (NeuroSAFE) during robot‐assisted laparoscopic radical prostatectomy
20217 citationsauthor #5
Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study
202010 citationsauthor #1
Assessing the Outcome of Holmium Laser Enucleation of the Prostate by Age, Prostate Volume, and a History of Blood Thinning Agents: Report from a Single-Center Series of >1800 Consecutive Cases
202033 citationsauthor #8
Retrograde ejaculation after holmium laser enucleation of the prostate (HoLEP)—Impact on sexual function and evaluation of patient bother using validated questionnaires
202021 citationsauthor #9
Definition of a structured training curriculum for holmium laser enucleation of the prostate
20202 citationsauthor #19
The Silent Operation Theatre Optimisation System (SOTOS©) to reduce noise pollution during da Vinci robot-assisted laparoscopic radical prostatectomy
202013 citationsauthor #5
Efficacy and safety of artificial urinary sphincter (AUS): Results of a large multi‐institutional cohort of patients with mid‐term follow‐up
201868 citationsauthor #4
AMS‐800 Artificial urinary sphincter in female patients with stress urinary incontinence: A systematic review
201858 citationsauthor #14
Journal of Endourology and Videourology Our 2017 Reviewers
20180 citationsauthor #20
Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy
201763 citationsauthor #12
From "gold standard" resection to reproducible "future standard" endoscopic enucleation of the prostate: what we know about anatomical enucleation.
201778 citationsauthor #5
The effect of closure versus non-closure of the buccal mucosa donor site during substitution urethroplasty on oral pain and morbidity: Final findings of a randomized controlled trial
20172 citationsauthor #4
Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
201732 citationsauthor #19
SUBSTITUTION URETHROPLASTY WITH CLOSURE VERSUS NON‐CLOSURE OF THE BUCCAL MUCOSA GRAFT HARVEST SITE: FINAL RESULTS OF A RANDOMIZED CONTROLLED TRIAL WITH A DETAILED ANALYSIS OF PAIN AND MORBIDITY: PD60‐10
20170 citationsauthor #4
Management of Anterior Urethral Strictures in Adults: A Survey of Contemporary Practice in Germany
201717 citationsauthor #8
Tumor volume improves the long-term prediction of biochemical recurrence-free survival after radical prostatectomy for localized prostate cancer with positive surgical margins
201720 citationsauthor #12
Substitution Urethroplasty with Closure Versus Nonclosure of the Buccal Mucosa Graft Harvest Site: A Randomized Controlled Trial with a Detailed Analysis of Oral Pain and Morbidity.
201750 citationsauthor #10
PREVIOUS INCONTINENCE SURGERY AND SURGICAL VOLUME PREDICT SOCIAL CONTINENCE AND SURGICAL REVISION: RESULTS OF A LARGE MULTI‐INSTITUTIONAL STUDY.: MP46‐09
20170 citationsauthor #17
Previous incontinence surgery and surgical volume predict social continence and surgical revision: Results of a large multi-institutional study
20170 citationsauthor #17
The diagnosis of benign prostatic obstruction: Development of a clinical nomogram
201627 citationsauthor #11
Previous incontinence surgery significantly diminishes artificial urinary sphincter results: result of a large multicenter study.
20160 citationsauthor #4
Psychometric validation of a German language version of a PROM for urethral stricture surgery and preliminary testing of supplementary ED and UI constructs
201639 citationsauthor #15

TIMELINE

2004 666 citations

2005 38 citations

2006 38 citations

2007 547 citations

2008 862 citations

2009 153 citations

2010 787 citations

2011 150 citations

2012 294 citations

2013 236 citations

2014 236 citations

2015 899 citations

2016 370 citations

2017 262 citations

2018 126 citations

2020 79 citations

2021 75 citations

2022 38 citations

2023 138 citations

2024 118 citations

2025 15 citations

S. Ahyai

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT